OptiNose (OPTN)

Company Profile

Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S. and Norway.

Company profile

Ticker

OPTN

Exchange

NASDAQ

Website

www.optinose.com

CEO

Peter Miller

Incorporated

Delaware

Location

Pennsylvania

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co • Abbott Laboratories • Teva- Pharmaceutical Industries • Bristol-Myers Squibb • Lilly(Eli) & Co • Viatris • Abbvie • Celgene ...

SEC CIK

0001494650

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

OptiNose US, Inc. • Optinose UK, Ltd. ...

OPTN stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Latest filings (excl ownership)

View all

8-K

Departure of Directors or Certain Officers

16 Dec 22

8-K

Optinose Appoints Paul Spence as Chief Commercial Officer

15 Dec 22

8-K

Departure of Directors or Certain Officers

9 Dec 22

8-K

Optinose Announces Proposed Public Offering of Common Stock and Warrants

23 Nov 22

424B5

Prospectus supplement for primary offering

23 Nov 22

424B5

Prospectus supplement for primary offering

21 Nov 22

8-K

Entry into a Material Definitive Agreement

10 Nov 22

Optinose Reports Third Quarter 2022 Financial Results

10 Nov 22

8-K/A

Departure of Directors or Certain Officers

27 Sep 22

Transcripts

View all

OPTN

Earnings call transcript

2022 Q2

13 Aug 22

OPTN

Earnings call transcript

2022 Q1

12 May 22

OPTN

Earnings call transcript

2021 Q4

8 Mar 22

OPTN

Earnings call transcript

2021 Q3

16 Nov 21

OPTN

Earnings call transcript

2021 Q2

11 Aug 21

OPTN

Earnings call transcript

2021 Q1

9 May 21

OPTN

Earnings call transcript

2020 Q4

3 Mar 21

OPTN

Earnings call transcript

2020 Q3

7 Nov 20

OPTN

Earnings call transcript

2020 Q2

6 Aug 20

OPTN

Earnings call transcript

2020 Q1

10 May 20

Latest ownership filings

View all

SC 13G/A

KRUTTSCHNITT THEODORE H III

Financial summary

Financial statements Chart OPTN financial data

Quarter (USD)	Sep 22	Jun 22	Mar 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	61.12 mm	61.12 mm	61.12 mm	61.12 mm	61.12 mm	61.12 mm
Cash burn (monthly)	5.72 mm	1.93 mm	3.60 mm	4.93 mm	5.83 mm	5.56 mm
Cash used (since last report)	22.65 mm	7.63 mm	14.26 mm	19.55 mm	23.11 mm	22.02 mm
Cash remaining	38.47 mm	53.49 mm	46.86 mm	41.57 mm	38.01 mm	39.10 mm
Runway (months of cash)	6.7	27.8	13.0	8.4	6.5	7.0

Beta Read what these cash burn values mean

Financial data from OptiNose earnings reports.

Institutional ownership, Q3 2022

OPTN institutional ownership history Ownership history

49.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	4	51	-92.2%
Opened positions	1	7	-85.7%
Closed positions	48	3	+1500.0%
Increased positions	0	14	EXIT
Reduced positions	0	18	EXIT

13F shares	Current	Prev Q	Change
Total value	98.15 mm	181.00 mm	-45.8%
Total shares	41.51 mm	62.05 mm	-33.1%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Avista Capital Partners II GP	14.27 mm	$23.12 mm	0.0%
MVM Partners	12.50 mm	$20.25 mm	0.0%
MVM Partners	12.50 mm	$45.50 mm	NEW
Entrepreneurs Fund	2.24 mm	$9.27 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
MVM Partners	12.50 mm	+12.50 mm	NEW
FMR	0.00	-12.40 mm	EXIT
Bleichroeder	0.00	-3.78 mm	EXIT
Stonepine Capital Management	0.00	-2.62 mm	EXIT
Kingdon Capital Management, L.L.C.	0.00	-2.21 mm	EXIT
Vanguard	0.00	-2.00 mm	EXIT
Velan Capital Investment Management	0.00	-2.00 mm	EXIT
Massachusetts Financial Services	0.00	-1.77 mm	EXIT
GMT Capital	0.00	-1.11 mm	EXIT
Rice Hall James & Associates	0.00	-887.58 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

OPTN insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
13 Jan 23	Peter K Miller	Common Stock	Sell	Dispose S	No	No	1.77	29,664	52.51 k	853,384
13 Jan 23	Ramy A Mahmoud	Common Stock	Sell	Dispose S	No	No	0	8,148	0.00	185,920
13 Jan 23	Michael F Marino III	Common Stock	Sell	Dispose S	No	No	1.77	5,241	9.28 k	180,353
15 Dec 22	Paul Jr. Spence	Stock Option Common Stock	Grant	Acquire A	No	No	1.75	500,000	875.00 k	500,000